For example, IL-6 secreted by MSCs in response to paclitaxel or doxorubicin, resulted in the activation of STAT3 signaling pathway, promoting the growth of head and neck cancer, nasopharyngeal carcinomas as well as osteosarcoma [104,105,106]. This evidence concerns the gene IL6 and head and neck cancer.